CompletedEarly Phase 1NCT03027674

Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

Studying Dermatomyositis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pontificia Universidad Catolica de Chile
Principal Investigator
Cristian Vera-Kellet, MD
Connective Tissue Diseases Unit, Department of Dermatology Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Intervention
10% nifedipine cream(drug)
Enrollment
10 enrolled
Eligibility
13-99 years · All sexes
Timeline
2016 – 2016

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03027674 on ClinicalTrials.gov

Other trials for Dermatomyositis

Additional recruiting or active studies for the same condition.

See all trials for Dermatomyositis →

← Back to all trials